Coronavirus

Pharmacy Times® interviewed Amanda Epp, MBA, the CEO of ScriptDrop, on how granting provider status to pharmacists can allow them to better support the health care system in the fight against COVID-19.

Study shows large reductions in visits to essential stores during the pandemic, such as pharmacies, but found essentially no reduction in non-essential visits to parks and other outdoor spots.

Researchers from 2 independent studies have found that SARS-CoV-2 may be more capable of infecting human cells due to the virus’ spike protein recognizing and binding to neuropilin-1.

Pharmacy students answered the question “Have you been able to build a professional pharmacy network during the pandemic?” The video is one part in the Pharmacy Times Student Café series.

Pharmacy Times® interviewed Ned Milenkovich, PharmD, JD, principal and co-chair of the Health Care Law practice group at Much Shelist, on how federal and state law may affect vaccine administration in accordance with recent HHS declarations.

Researchers suggest several modifications in the way health professionals manage patients with obesity during the COVID-19 pandemic.

Using several sources of data, researchers at Linköping University in Sweden developed a new method to predict flu epidemics.

Study suggests COVID-19 cases and deaths in the United States in the fall and winter will far exceed those of spring 2020 unless there is effective implementation of nationally coordinated efforts and preventive strategies.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

A new study suggests that more than 80% of COVID-19 patients could be vitamin D deficient.

Six of the patients with pernio/chilblains were long haulers with toe symptoms lasting at least 60 days, with 2 lab-confirmed patients with COVID toes lasting longer than 130 days, according to the study.

T-cells may offer immunity from COVID-19 and may be a more effective prevention option than a vaccine for patients with certain underlying conditions.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

A new study found that the COVID-19 death rate in New York has dropped significantly since March.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on how growth in the health care and biotech industry can support economic revitalization during and following the COVID-19 pandemic among community and retail pharmacies.

Divergent research findings come as investigators seek to understand whether plasma treatments are effective in patients with COVID-19.

The impact of engineering controls, such as ventilation systems, is greater on limiting the spread of COVID-19 than the impact of the most widely applied measures.

Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.

Patients with mild or no symptoms of COVID-19 may be infectious for just 10 days.

The investigators found that 72% of participants would likely take the vaccine based on data collected from the previously validated COVID-SCORE survey of a sample of more than 13,400 individuals from 19 countries that were hard-hit by the virus.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

They can help patients improve inhalation technique, ensuring better medication adherence.

Pharmacy Times® interviewed John Beckner, RPh, the senior director of strategic initiatives at the NCPA, on the importance of American Pharmacists Month in acknowledging the critical role of pharmacists in supporting the US health care system.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Pharmacy Times spoke with Maggie Ryman, a member of McKesson’s Critical Care Drug Task Force, about anticipating hospital pharmacy needs during COVID-19 and American Pharmacist Month.

Because restrictions have led to widespread demoralization and frustration, the authors said there has been renewed public interest natural herd immunity approaches.

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

Thirty-four percent of people in Turkey and 17% of people in the UK report that they are “hesitant” about a COVID-19 vaccine, primarily based on the their beliefs regarding the origin of the virus.

Patients with current or former smoking status may be at an increased risk of severe illness due to COVID-19.

Physicians and scientists tested several oral and nasopharyngeal rinses in a laboratory setting for their ability to inactivate human coronaviruses that are similar in structure to SARS-CoV-2.